- Research works
- 24 ▲ 625% vs 2013–17
- Citations
- 410 16.8 per fractional work
- Top-10% rate
- 0.7% record average 16.5%
- Open access
- 19% world 28%
Not ranked overall: Barricaid (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.4×. Every wedge is a field page.
Which keywords describe research at Barricaid (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Surgical Treatment, Low Back Pain, Cancer Immunotherapy, Immunotherapy, Tumor Regression, Degenerative Disc Disease, Intervertebral Disc and Lumbar Disc Degeneration.
- Chronic Pain
- Bacterial Therapy
- Dendritic Cells
- Acetabular Fractures
- Immunity
- Innate Immunity
- Complications
- CAR T Cells
- Lumbar Disc Degeneration
- Degenerative Disc Disease
- Immunotherapy
- Low Back Pain
- Surgical Treatment
- Cancer Immunotherapy
- Tumor Regression
- Intervertebral Disc
- Epidemiology
- Chimeric Antigen Receptor
- Tumor Microenvironment
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Antigen Presentation
- Pelvic Fractures
- Biosensors
- Tumor Targeting
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 25 words, with their numbers
- Surgical Treatment4▲ 72×2 topics
- Low Back Pain3▲ 82×2 topics
- Cancer Immunotherapy3▲ 90×2 topics
- Immunotherapy3▲ 19×3 topics
- Tumor Regression3▲ 137×2 topics
- Degenerative Disc Disease2▲ 114×2 topics
- Intervertebral Disc2▲ 152×1 topic
- Lumbar Disc Degeneration2▲ 152×1 topic
- Epidemiology2▲ 2.4×6 topics
- CAR T Cells2▲ 181×1 topic
- Chimeric Antigen Receptor2▲ 181×1 topic
- Complications2▲ 14×3 topics
- Tumor Microenvironment1▲ 16×2 topics
- Innate Immunity1▲ 15×2 topics
- Immune Checkpoint Blockade1▲ 89×1 topic
- Immunity1▲ 15×2 topics
- PD-1 and PD-L11▲ 89×1 topic
- Acetabular Fractures1▲ 182×1 topic
- Antigen Presentation1▲ 47×1 topic
- Dendritic Cells1▲ 41×1 topic
- Pelvic Fractures1▲ 182×1 topic
- Bacterial Therapy1▲ 93×1 topic
- Biosensors1▲ 7.2×2 topics
- Chronic Pain1▲ 18×3 topics
- Tumor Targeting1▲ 31×1 topic
Which research topics does Barricaid (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Cancer Research and Treatments, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 2 works
- 2 Cancer Research and Treatments Biotechnology 1 works
- 3 Immunotherapy and Immune Responses Immunology 1 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 6 Forensic Fingerprint Detection Methods Safety Research 0 works
- 7 Extracellular vesicles in disease Molecular Biology 0 works
- 8 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 9 Click Chemistry and Applications Organic Chemistry 0 works
- 10 Cancer Cells and Metastasis Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Barricaid (United States)'s research output changed?
Output in 2018–2022 was 625% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Woburn
- GEI Consultants
- Scientific Systems (United States)
- Skyworks Solutions (United States)
- Microscale (United States)
- Aptima (United States)
- Frequency Therapeutics (United States)
- Systems and Technology Research (United States)
- Magnolia Solar (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.